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Abstract 
 This study reports on the development and psychometric evaluation of a self-
report assessment of the severity of symptoms of emetophobia.  Using a sample of 95 
individuals with emetophobia, and a matched sample of 90 control participants, a 13-
item inventory was developed that showed a clear three-factor structure.  The EmetQ-
13 had good internal consistency (α = .82 in the clinical sample, and α = .85 in the 
control sample), and one-week test-retest reliability (rxx= .76).  The EmetQ-13 
showed significant correlations with another measure of emetophobia symptoms, the 
Specific Phobia of Vomiting Inventory, and related constructs such as disgust 
sensitivity.  The measure showed excellent ability to classify emetophobic and non-
emetophobic individuals, with correct assignment in 96.2% of cases.  The EmetQ-13 
also correlated significantly with a behavioural approach test using a vomit-like 
stimulus.  The initial evaluation of the EmetQ-13 suggests that it is a reliable and 
valid measure for the assessment of emetophobia. 
 
KEYWORDS:  Emetophobia, fear of vomiting, specific phobia, questionnaire 
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The Emetophobia Questionnaire (EmetQ-13): Psychometric Validation of a Measure 
of Specific Phobia of Vomiting (Emetophobia). 
 
1.0 Introduction 
Emetophobia (specific phobia of vomiting) is an anxiety disorder 
characterised by a preoccupation with fear that oneself or others may vomit (Boschen, 
2007).  Individuals may avoid people, places, foods or other stimuli that they 
associate with increased risk of nausea or vomiting.  Specific data on prevalence is 
limited with clinical levels of specific phobia of vomiting having an estimated lifetime 
and 12 month prevalence of 0.2%, and a point prevalence of 0.1% (Becker et al., 
2007).  The condition is much more common in females (Veale & Lambrou, 2006).  
Limited available data suggests that emetophobia typically has an onset before 
adulthood, and a chronic course (Lipsitz, Fyer, Paterniti, & Klein, 2001).  
Emetophobia is also associated with considerable functional impairment (Veale & 
Lambrou, 2006) and interference in eating (Veale, Costa, Murphy, Ellison, 2012). 
There is some evidence for associative learning in emetophobia whereby vomiting 
becomes associated with an unrelated life event or an aversive consequence (Veale, 
Murphy, Ellison, Kanakam, Costa, 2012).  
Previous authors have specified a range of theoretically-derived treatment 
techniques that may be useful in the treatment of emetophobia (e.g., Boschen, 2007; 
Veale, 2009).  Despite this, however, there remain no large studies, which assess the 
efficacy of these treatment methods.  Most investigations of emetophobia treatment 
have been case studies (e.g., Hunter & Antony, 2009; Lesage & Lamontagne, 1985; 
McFadyen & Wyness, 1983), and the largest study to date has involved only seven 
patients (Philips, 1985). 
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While general measures exist to assess the broad range of specific phobias, 
there are no measures which provide an assessment of the specific symptoms of 
emetophobia.  A precursor to conducting larger scale treatment outcome research is 
the existence of a reliable, valid measure of emetophobia.  Previous case reports have 
assessed outcome using either behavioural methods, or other individualised outcomes 
such as progress through an exposure hierarchy.  While these individualised measures 
of outcome are suitable for case studies, they are not a viable option for conducting 
treatment of groups of individuals.  Furthermore, although they demonstrate good 
face validity, their psychometric properties are unknown.   
One major impediment to the development of a psychometrically validated 
measure of emetophobia is the low prevalence of the condition.  Full psychometric 
assessment of the reliability and validity of a new measure of emetophobia requires 
samples that are much larger than those used in all previous studies of the condition. 
One previous scale has been developed to assess severity of emetophobia 
symptoms.  The Specific Phobia of Vomiting Inventory (SPOVI; Veale, Ellison, 
Boschen, Costa, Whelan, Muccio, & Henry, 2012) was developed independently of 
the measure presented in the current paper, with eventual collaboration between these 
two research groups after these scales were developed.  Although there is overlap in 
some symptoms of emetophobia that are assessed by each of these scales, there is also 
divergence between the two scales in some areas of focus.  For example, the SPOVI 
includes items related to monitoring of vomit-related threat, while the EmetQ 
differentiates between avoidance of of situations/movement/travel and avoidance 
other others who may be at perceived increased risk of vomiting. 
 
Running head: EMETOPHOBIA QUESTIONNAIRE 5 
 
The current study aimed to conduct the preliminary psychometric 
investigation of a self-report measure of emetophobia symptoms.  From an initial item 
pool, factor analysis was used to arrive at a brief measure with a sound factor 
structure.  Following this, the psychometric properties of the scale were assessed. 
  
2.0 Study One - Method 
2.1 Participants 
2.1.1 Emetophobic Sample. We recruited participants with emetophobia (N = 
95) either from patients seeking treatment (n = 25) or 3 internet support groups (Gut 
Reaction, International Emetophobia Society, and Anxiety UK; n = 70). All 
participants had to fulfil DSM-IV criteria for emetophobia diagnosed with the 
Structured Clinical Interview for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 
1996) using a face-to-face interview or over the telephone.   Interviewers using the 
SCID were either psychologists or psychiatrists experienced in its use, or a clinical 
research worker trained in the use of the SCID.  Inter-rater reliability of these 
diagnoses was not assessed. 
 Although the SCID was not used to confirm the absence of an emetophobia 
diagnosis, we included individuals who self-reported fear of vomiting.  Additionally 
we planned to exclude participants with any condition that may increase the 
likelihood or frequency of vomiting (e.g., pregnancy, current prescription medication 
or illicit drugs, or other health/medical problems), however no participants were 
excluded on the basis of these criteria.  A total of 95 individuals with emetophobia 
were recruited, with a mean age of 32.61 years (SD = 12.09).  As expected, the 
majority (89, 93.7%) were female.  A total of 55.8% were married or cohabiting, with 
38.9% being single.  Demographic details including employment and marital status 
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are presented in Table 1.  A total of 63.4% of the Emetophobic group had no 
comorbid diagnoses, while 21.1% had one comorbid diagnosis, and 15.5% had two or 
more comorbid diagnoses.  Comorbid conditions in patients from the emetophobia  
sample were major depressive disorder (n =  8, 11.3%), generalized anxiety disorder 
(n = 8, 11.3%), obsessive-compulsive disorder (n =  6, 8.5%), somatisation disorder (n 
= 5, 7.0%), panic disorder without agoraphobia (n = 4, 5.6%), social anxiety disorder 
(n = 4, 5.6%), agoraphobia without a history of panic disorder (n = 2, 2.8%), 
hypochondriasis (n = 1, 1.4%), and other specific phobia (n= 1, 1.4%). 
2.1.2 Control Sample.  For comparison, a control sample was recruited using 
the MindSearch database of the Institute of Psychiatry at King’s College London, a 
database of over 3500 community volunteers who have previously registered to 
participate in research studies.  Individuals were recruited with the aim of providing a 
sample which was similar in demographics to the Emetophobic sample.  Individuals 
with greater risk of vomiting (e.g., presence of eating disorder including vomiting 
behaviour, recent overdose with vomiting, regular binge drinking and vomiting, use of 
illicit drugs or prescription medication, presence of a medical disorder such as 
migraine, or current pregnancy) were excluded in order to match the frequency of 
vomiting to the emetophobia group.  A total of 90 individuals completed the 
questionnaire package through an online website.  The Control group participants had 
a mean age of 32.47 years (SD = 11.00), and the majority (86, 95.6%) were female.  
Demographics for the Control sample are presented in Table 1. 
2.1.3 Anxious Control Sample.  To ensure the specificity of the EmetQ-13 to 
emetophobic individuals, a comparison sample of 20 anxious individuals with other 
(non-emetophobia) disorders were recruited.  Basic demographic details are provided 
in Table 1.  There were 12 participants with a primary diagnosis of obsessive-
Running head: EMETOPHOBIA QUESTIONNAIRE 7 
 
compulsive disorder, 4 with body dysmorphic disorder, 2 with panic disorder with 
agoraphobia, and 2 with social phobia.  These participants were recruited from a 
specialist anxiety and body dysmorphic disorder treatment service.  All were screened 
for the presence of emetophobia using a clinical interview.  Other diagnoses in 
addition to the primary diagnosis were not recorded, except to rule out the presence of 
emetophobia. 
 
2.2 Materials and Procedure 
Participants from all samples completed a collection of questionnaires, either 
online or in a pen-and-paper format.  Measures were selected for the purpose of 
assessing the validity of the new scale, and measuring associated psychopathology 
and functioning.  All responses were entered onto a computer for statistical analysis. 
2.2.1 Emetophobia Questionnaire (EmetQ-13).  The EmetQ-13 was derived 
as a brief self-report measure of symptoms associated with specific phobia of 
vomiting.  An initial item pool of 21 items was generated based on case reviews of 8 
individuals previously diagnosed with emetophobia.  Each item was constructed in the 
form of a Likert-type scale in which the respondent read the item (e.g., “I avoid 
children who may be likely to vomit.”) by circling a number ranging from 1 
(“Strongly Disagree) to 5 (“Strongly Agree”).  A total score was computed by 
summing scores for all 13 individual items. 
2.2.2 Specific Phobia of Vomiting Inventory (SPOVI). The SPOVI (Veale 
et al., 2012) is a 14 item self-report measure of symptoms associated with specific 
phobia of vomiting.  It is the only other standardized measure of emetophobia, and 
has established sound reliability (α = .91), and validity in the assessment of 
emetophobia symptoms. 
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The SPOVI was developed independently of the EmetQ, with subsequent 
collaboration after data collection between the two research groups.  While the EmetQ 
and SPOVI overlap in assessment of some emetophobia symptoms, the SPOVI 
includes additional items related to threat-monitoring, while the EmetQ differentiates 
avoidance into avoidance of situations/movement/travel and avoidance other others 
who may be at risk of vomiting. 
2.2.3 Disgust Scale – Revised (DS-R).  The DS-R (Olatunji et al., 2007; van 
Overveld, de Jong, Peters, & Schouten, 2011) is a 25-item self-report measure of an 
individual’s propensity to experience disgust.  The DS-R asks the respondent to rate 
whether certain stimuli would be perceived as disgusting, as well as their level of 
disgust to a list of situations. 
2.2.4 Obsessive-Compulsive Inventory (OCI).  The OCI (Foa, Kozak, 
Salkovskis, Coles, & Amir, 1998) is a 42-item self-report measure of symptoms of 
obsessive-compulsive disorder.  The OCI covers a wide range of OCD symptoms, and 
has established reliability and validity in the assessment of OCD. 
2.2.5 Patient Health Questionnaire (PHQ-9).  The PHQ-9 (Kroenke, 
Spitzer, & Williams, 2001) is a brief self-report measure of depressive symptoms, 
based on nine DSM-IV symptoms of major depressive disorder.  The instrument has 
good reliability (α = .86 - .89), and is a valid measure of severity of depression 
symptoms. 
2.2.6 Generalized Anxiety Disorder (GAD-7).  The GAD-7 (Spitzer, 
Kroenke, Williams, & Löwe, 2006) is a seven item instrument designed to screen for 
GAD symptoms, and quantify their severity.  It has high sensitivity and specificity to 
GAD, as well as strong reliability and validity in the assessment of GAD symptoms. 
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2.2.7 Health Anxiety Inventory (HAI).  The HAI (Salkovskis, Rimes, 
Warwick, & Clark, 2002) is a 14 item self-report measure designed to assess 
symptoms of health anxiety and hypochondriasis.  The measure shows high 
reliability, differentiates between health anxiety and other conditions, is sensitive to 
change during treatment, and correlates highly with clinician ratings. 
2.2.8 Work and Social Adjustment Scale (WSAS).  The WSAS (Mundt, 
Marks, Shear, & Greist, 2002) is designed to assess an individual’s current 
functioning using a brief, five-item, self-report questionnaire.  The measure shows 
acceptable internal consistency, and correlates with severity measures of depression 
and obsessive-compulsive disorder.  The measure is also sensitive to treatment 
effects. 
 
3.0 Study One - Results 
3.1 Item Reduction and Factor Analysis 
 The current study was the first investigating the EmetQ-13, and as such 
exploratory factor analytic methods were used to reduce an item pool to a subset of 
items which yielded a robust, interpretable factor structure.  Beginning with the 
original 21-item pool, a series of exploratory factor analyses were conducted using 
only the Emetophobic sample.  At each iteration, maximum likelihood factor 
extraction was used, followed by a promax rotation with Kaiser normalization.  The 
number of factors extracted was based on a cutoff eigenvalue of 1.0.  At each stage, 
items were retained only if they met all of the following criteria: communality > .3; 
factor loading on at least one factor of  > .4; no complex factor loadings, indicated by 
loading on a single factor only of >.4.  After each factor analysis, items which did not 
meet all of these criteria were eliminated before running the next iteration.  A total of 
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four iterations were required to produce a final subset of 13 items which loaded on 3 
separate factors.  Table 2 shows the items which were eliminated at each step, as well 
as measures of adequacy of sampling variance.  The final 13-item 3-factor solution 
accounted for 64.07% of the variance.  Loadings of individual items, as well as final 
communality statistics, are shown in Table 3.   
 Factor I included 6 items and described avoidance symptoms, focused on 
travel, movement, or locations where there are no facilities or medical help.  Factor II 
was comprised of 3 items which centred on themes of dangerousness of exposure to 
vomit stimuli.  Factor III consisted of 4 items which were predominantly focused on 
avoidance of others who may vomit.  Subscale totals were computed by finding the 
arithmetic mean of the items for each subscale, based on their primary factor loadings 
from Table 3.  A total EmetQ-13 score was computed by summing the score for all 13 
items.  Correlations between subscales and the total score, for both the clinical and 
control samples, are presented in Table 4. 
 
3.2 Reliability - Internal Consistency 
Separate evaluations of internal consistency were conducted for the EmetQ-13 
in the Emetophobic and Control samples.  Cronbach’s alpha for the 13-item scale was 
α = .82 for the clinical, and α = .85 for the control sample, indicating good internal 
consistency without substantial item redundancy.  Cronbach’s α for the other scales 
used in this study are presented in Table 5 and Table 6. 
 
3.3 Reliability – Test-Retest 
 Temporal stability of the measure was assessed by examining scores by the 
same participants taken 1 week apart.  All participants from the Study 1 emetophobic 
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group were invited to participate in the retest phase, with a total of 31 participants 
completing the EmetQ-13 at both timepoints.  Test-retest reliability for the total scale 
was .76 (p < .001), while test-retest reliabilities for the three subscales were .79, .76, 
and .63 (all p < .001).  
 
3.4 Validity – Concurrent and Discriminant 
One assessment of the validity of the EmetQ-13 is to examine its concurrent 
validity through correlations with related measures of psychopathology and other 
constructs.  We examined the relationship between the EmetQ-13 and the only other 
measure of emetophobia symptoms, the SPOVI.  Correlations between these two 
measures were r = .45 (p < .001) in the clinical sample, and r = .25 (p = .02) in the 
control sample.  The correlation between the EmetQ-13 subscales and the SPOVI in 
the emetophobia sample was .41 (p < .001), .21 (p = .047), and .26 (p = .013) for 
Factor I, II, and III respectively.  The EmetQ-13 correlated significantly with disgust 
as measured by the DS-R in both the Emetophobic sample (r = .33, p = .002) and the 
Control sample (r = .56, p < .001).  Health anxiety symptoms measured by the HAI 
also showed significant correlations with emetophobia symptoms in the clinical and 
non-clinical samples (r = .50, p < .001 and r = .26, p = .02, respectively).  
Correlations between the EmetQ-13 and other measures of psychopathology such as 
depression, generalized anxiety, obsessive-compulsive symptoms were all significant 
in the clinical sample (see Table 5).  In contrast, in the non-clinical sample EmetQ-13 
scores were only significantly correlated with obsessive-compulsive symptoms (see 
Table 6). 
 
3.5 Validity – Theory-Consistent Group Differences 
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 A key test of the validity of the new measure was whether it showed 
differences in scores between a group of individuals diagnosed with emetophobia and 
a control group which did not have the condition. We examined each of the EmetQ-13 
subscales, as well as the total score, comparing scores between the Emetophobic and 
Control groups using independent t-tests.  As is shown in Table 7, each of the 
subscales demonstrated a significantly higher score in the Emetophobic group 
compared to the Control group.  The same significant difference was observed 
between the groups on the overall EmetQ-13 total score (see Table 7). 
A similar comparison was made between the emetophobia group, and a group 
of 20 anxious individuals.  Individuals from the emetophobia group had significantly 
higher EmetQ-13 total scores than individuals with other non-emetophobic disorders, 
as well as on Factor I and Factor III (see Table 7). 
 
3.6 Validity – Diagnostic Classification 
 We assessed whether the subscales of the EmetQ-13 were able to reliably 
classify participants into either the Emetophobic or Control groups using a logistic 
regression with the subscales entered simultaneously as predictors, and group as the 
dependent variable.  Results demonstrated that the EmetQ-13 was successful at 
predicting diagnostic status (Nagelkerke R
2
 = 0.95, χ2 = 227.65, p < .001).  When the 
resulting regression equation was used to classify individuals as either emetophobic or 
control participants, an overall accuracy of 96.2% was obtained, indicating excellent 
ability of the instrument to differentiate between clinical and control participants.  A 
total of 86 (95.6%) of the control group were correctly identified as being non-
clinical, while 90 (96.8%) of the emetophobic group were correctly identified as 
belonging to the clinical sample.
1
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 Examination of the sensitivity and specificity of the EmetQ-13 in determining 
caseness was conducted using a receiver operating curve procedure.  Figure 1 shows 
the ROC curve of the EmetQ-13.  The total area under the curve determined in the 
ROC analysis was 0.988 (p < .001).  As can be seen, the instrument displays a good 
ability to balance sensitivity and specificity. 
 A range of clinical cut-off scores were considered based on the results of the 
ROC analysis.  Table 8 presents the sensitivity and specificity for a range of different 
cutoff scores, with a score of > 22 being determined as the most appropriate cut-off 
score to balance sensitivity and specificity. 
 
3.7 Validity – Sensitivity to Treatment Effects 
The use of the EmetQ-13 as a measure of treatment outcome requires it to be 
sensitive to changes in symptom severity in successful treatment of emetophobia.  A 
total of 12 individuals diagnosed with emetophobia by a clinical psychologist or 
psychiatrist specialising in treatment of the condition were treated using a cognitive 
behavioural intervention based on the principles outlined by Boschen (2007) and 
Veale (2009), including imagery rescripting, exposure to situations and stimuli 
associated with vomiting, reducing safety behaviours, and cognitive restructuring.  
These participants were a subset of those used in the Study 1 analyses.  Each 
participant received up to 12 weekly 1-hour sessions.  Individuals showed significant 
reduction in emetophobia symptoms, as measured by the EmetQ-13, between pre-
treatment and post-treatment assessments (MPre = 52.00, SDPre = 8.64, MPost = 43.33, 
SDPost =  6.89, d = 1.117, Wilcoxin Signed Ranks Test Z = 3.063, p = .002).  
Additionally, changes in EmetQ-13 scores during treatment were strongly correlated 
with changes in SPOVI scores (r = .70). 
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4.0 Study Two - Method 
4.1 Participants 
To assess the relationship between the EmetQ-13 and a behavioural measure 
of ability to approach a vomit stimulus, a mixed sample of student and clinical 
individuals were recruited.  The use of a combined sample was conducted to ensure 
that there would be a range of scores on both the EmetQ-13 and the behavioural 
approach test.  The combined sample consisted of 116 undergraduate psychology 
students, 10 individuals with panic disorder (with and without agoraphobia) recruited 
from a local support group, and 6 individuals with emetophobia recruited from a 
private clinical psychology practice in Brisbane, Australia.  All diagnoses were made 
by an experienced clinical psychologist on the basis of a clinical interview.  The 
combined participant group consisted of 100 females and 32 males, with a mean age 
of 24.11 years (SD = 11.91). 
 
4.2 Measures and Procedure 
Participants completed the EmetQ-13 in addition to a Behavioural Approach 
Test (BAT) designed to assess their ability to approach a vomit-like stimulus.  The 
stimulus was mixed according to the formula used by previous authors in their 
treatment of an individual with vomit phobia (McFadyen & Wyness, 1983).  
Approximately two litres of the substance was contained in a plastic container four 
metres from the entrance to a room.  Participants were given instructions as detailed 
in Appendix B.  Higher scores on the BAT reflected higher levels of avoidance of the 
vomit-like substance.  Participant instructions and scoring criteria for the BAT are 
detailed in Appendix B. 
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5.0 Study Two – Results 
5.1 Validity – Behavioural Approach Test 
 Correlations between the EmetQ-13 total and subscale scores, and the results 
of the behavioural approach test were compared as a test of validity of the new scale 
against an external behavioural task.  The EmetQ-13 was significantly correlated with 
both an individual’s predicted ability to approach the vomit stimulus (r = .36, p = 
.003), and their actual approach score (r = .39, p = .001). 
 
6.0 Discussion 
The current report describes the development and initial psychometric 
evaluation of a self-report measure of emetophobia symptoms.  From an initial item 
pool of 21 items, a series of factor analyses were used to derive a short, 13 item 
questionnaire in which all items clearly loaded on only one of the three factors.  The 
scale showed good levels of internal consistency, especially given the small number 
of items.  Temporal stability over one week was also acceptable.  The EmetQ-13 
correlated with other measures of related symptoms, including the only other measure 
of emetophobic symptoms.  As expected, EmetQ-13 total and subscale scores were 
higher in individuals diagnosed with emetophobia.  A particular strength of the 
EmetQ-13 was its ability to differentiate between individuals with emetophobia and a 
control sample, and the scale showed high levels of sensitivity and specificity to the 
diagnosis of emetophobia.  Additionally, the EmetQ-13 was sensitivity to the effects 
of treatment in a small group of individuals treated for emetophobia.  Finally, the 
EmetQ-13 shows a significant relationship with a behavioural measurement of 
avoidance of a vomit stimulus. 
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The correlation between the EmetQ and the only other validated measure of 
emetophobia symptoms, the SPOVI, was significant but moderate in strength (r = 
.45).  This suggests that while the EmetQ and SPOVI assess some similar symptoms 
of emetophobia, they are not assessing precisely the same features.  Both instruments 
assess emetophobia symptoms, although the focus of each measure is different. The 
EmetQ overlaps on the factor of avoidance but separates into two distinct factors of 
avoidance of situations and movement, and avoidance of people who may vomit. The 
EmetQ also includes a third factor on misinterpretation of seeing or smelling vomit in 
anticipation of vomiting by oneself, which does not occur on the SPOVI. The SPOVI, 
alternatively, covers some symptoms of avoidance, but also contains items that assess 
an individual’s monitoring of the threat of vomiting (for example excessive worry 
about vomiting; ruminating about reasons feeling nauseous or being self-focussed 
monitoring whether one feels ill; seeking reassurance about vomiting).  The moderate 
correlation between the two measures is likely to be a reflection of this imperfect 
overlap in item content.  Weak correlations between the SPOVI and EmetQ Factor II 
and III subscales also demonstrates that the EmetQ and SPOVI are assessing different 
aspects of emetophobia symptoms. 
The EmetQ also showed a range of correlations with other measures of 
psychopathology and functioning.  The strongest correlation (in the clinical sample) 
was between the EmetQ and the WSAS.  This strong relationship between 
emetophobia symptoms and work and social adjustment is likely to reflect the impact 
of emetophobia symptoms on everyday functioning.  Emetophobia is known to 
significantly impair functioning, causing marked distress (Lipsitz, et al., 2001), and 
this correlation is consistent with this previous research. 
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The next strongest relationship in the clinical sample was observed between 
emetophobic symptoms and symptoms of hypochondriasis.  This correlation is likely 
to be the result of concerns about becoming ill, where the individual may be exposed 
to increased risk of vomiting as part of that illness.  This correlation was also 
significant in the non-clinical (community) sample. 
Significant relationships in the clinical and community samples between 
emetophobia symptoms and disgust sensitivity (the propensity to experience disgust 
and find this experience aversive) are also consistent with previous findings (van 
Overveld, de Jong, Peters, van Hout, & Bouman, 2008) and models of emetophobia 
(e.g., Boschen, 2007).  Individuals with emetophobia may be predisposed to 
developing the condition as a result of increased experience and aversiveness of 
disgust reactions.  When individuals experience more severe and frequent disgust 
reactions, this may lead to stronger tendencies to avoid stimuli and reactions 
associated with these, such as nausea. 
Associations between emetophobia symptoms and symptoms of other 
conditions such as depression, generalized anxiety disorder, and obsessive-
compulsive disorder are consistent with correlations observed between anxiety and 
depression measures previously (e.g., Boschen & Oei, 2006; Boschen & Oei, 2007; 
Clark & Watson, 1991).  These relationships are generally attributed to a non-specific 
general distress factor, also referred to as negative affectivity, shared across the 
anxiety and depressive disorder spectrum.  As such, the correlations observed in the 
current study are consistent with these. 
Differences in correlations between the community and clinical (emetophobic) 
samples are most likely due to the restriction in range in the non-clinical samples 
scores.  The non-clinical (community) sample reported low levels of specific 
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psychopathology symptoms on measures such as the OCI, PHQ-9, and GAD-7.  
Where measures have greater variability in non-clinical samples (e.g., in disgust 
sensitivity as measured by the DS-R), the relationships between this variable and 
emetophobia symptoms are preserved.  
The current research has several implications that are noteworthy.  The 
development of a brief self-report measure of emetophobia symptoms allows for the 
reliable and valid measurement of these symptoms in a variety of contexts.  In 
research settings, the ability to reliably measure emetophobia symptoms allows for 
these symptoms to be measured in larger cohorts, as part of treatment outcome 
studies.  Within clinical contexts, the EmetQ-13 can be used to assess severity of 
emetophobia symptoms, and to evaluate changes in these that may occur during 
treatment.  The high levels of sensitivity and specificity of the instrument also suggest 
a use as a screening measure for the presence of emetophobia in either clinical or 
research contexts. 
Despite the strengths of the measure, there are several limitations that should 
be acknowledged, both in the measure itself, and the methodology of the current 
study.  Firstly, the elimination of several items during the repeated iterations of factor 
analysis means that several symptoms of emetophobia that were covered by the larger 
item pool are no longer assessed.  Although this has left a final questionnaire that is 
brief, and has a robust factor structure, it does mean that the revised measure is not as 
broad in its coverage of emetophobia symptoms.  This may have implications for the 
use of the measure in research and clinical contexts.  For example, if treatment of an 
individual with emetophobia is more effective in reducing symptoms that are not 
covered by the 13-item EmetQ-13, than those that are retained in the shorter measure, 
then this may underestimate the amount of change that has occurred due to treatment.  
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As such, it is recommended that the EmetQ-13 be used in conjunction with detailed 
clinical interviews that cover the full range of symptoms, or other measures of 
emetophobia symptoms such as the SPOVI. 
The second set of limitations concern the need for further psychometric 
investigation of the EmetQ-13.  There is a need to replicate the three-factor structure 
to ensure that the structure is not peculiar to our sample.  The low prevalence rate of 
emetophobia, and the difficulty in recruiting large sample sizes with which to conduct 
confirmatory factor analysis, is something that may be addressed in future through 
larger scale research projects, and possibly online assessment and treatment of 
individuals  with emetophobia from other parts of the world.  The issue of sample size 
is also present in our assessment of the relationship between the EmetQ-13 and the 
BAT, which was limited in the number of emetophobic individuals who were 
available to participate in the BAT.  Additionally, our tests of differences between 
pre-treatment and post-treatment individuals, and between emetophobic and other 
anxiety disorders, were based on small samples.  Although these comparisons yielded 
the expected results, with noteworthy effect sizes, replication of these results with a 
larger sample would provide stronger evidence of the validity of the EmetQ-13. 
 
6.1 Conclusion 
The EmetQ-13 is a brief, 13-item, self-report questionnaire designed to 
measure the severity of symptoms of emetophobia (specific phobia of vomiting).  
Preliminary assessment of its factor structure, internal consistency, temporal stability, 
concurrent validity, sensitivity to group differences, sensitivity to treatment effects, 
and sensitivity/specificity to a diagnosis of emetophobia are promising.  Further 
research is warranted to provide additional support for the psychometric qualities of 
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the measure especially in those who have another anxiety disorder who experience 
nausea as a symptom of their anxiety or who have a fear of vomiting but do not reach 
criterion for a specific phobia.  
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A reviewer suggested that we also test the ability of the EmetQ-13 to differentiate 
between our emetophobia group and the combined control and anxious control 
groups.  The EmetQ-13 is also able to successfully differentiate between these 
two groups in a logistic regression (Nagelkerke R
2
 = 0.75, χ2 = 159.32, p < 
.001, 87.7% correctly classified) 
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Appendix A 
The Emetophobia Questionnaire (EmetQ-13) 
 
Instructions.  The following questionnaire is designed to measure the severity of fear 
of vomiting over the past week, including today.  Please read each question 
carefully and, on the 1 to 5 scale indicate your response by circling the appropriate 
number next to each question.   
 
1 2 3 4 5 
Strongly 
Disagree 




1 I avoid air travel because I may become nauseous/vomit. 1 2 3 4 5 
2 I avoid other forms of transport because I may become 
nauseous/vomit. 
1 2 3 4 5 
3 I avoid sea travel (boats, etc.) because I may become 
nauseous/vomit. 
1 2 3 4 5 
4 I avoid places where there are no facilities to cater if I 
become nauseous/vomit. 
1 2 3 4 5 
5 I avoid places where there is no medical attention, 
because I may become nauseous/vomit. 
1 2 3 4 5 
6 I avoid fast-moving activities like rides at the theme park, 
because I may vomit. 
1 2 3 4 5 
7 If I see vomit, I may be sick myself. 1 2 3 4 5 
8 If I smell vomit I may be sick myself. 1 2 3 4 5 
9 Exposure to vomit can cause sickness and/or illness. 1 2 3 4 5 
10 I avoid adults who may be likely to vomit. 1 2 3 4 5 
11 I avoid children who may be likely to vomit. 1 2 3 4 5 
12 I avoid places where others may vomit. 1 2 3 4 5 
13 I notice physical anxiety symptoms when exposed to 
vomit. 
1 2 3 4 5 
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Appendix B 
The Emetophobia Behavioural Approach Test Scale 
 
Instructions: You are to enter this room where there is a clear plastic container, four 
metres from the doorway.  In the container there is an amount of vomit or vomit-like 
liquid.  You are to enter the room, walk slowly to the vomit container, immerse both 
your hands into the liquid, and raise some of the liquid towards your face, to a level at 
which you can clearly smell the odour.  Once you enter the room, you may stop your 
approach at any stage where you feel you can go no further.  You should not feel 









Withdraws from the task after the task is described. 
9 Agrees to the task, but then refuses to enter the stimulus room. 
8 Enters the room, just inside the doorway. 
7 Stands no more than 3 metres from the vomit stimulus. 
6 Stands no more than 2 metres from the vomit stimulus. 
5 Stands no more than 1 metre from the vomit stimulus. 
4 Stands within 1 metre of the vomit stimulus. 
3 Immerses one hand into the vomit stimulus. 
2 Immerses both hands into the vomit stimulus, for less than 30 seconds. 
1 Immerses both hands into the vomit stimulus, for at least 30 seconds. 
0 Immerses both hands and raises the vomit stimulus to the point where 
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Table 1. 
Demographic Characteristics of the Emetophobia and Control Samples. 
Variable Emetophobia Group  
(N = 95) 
Community Control Group  
(N = 90) 
Anxious Control Group 
(N = 20) 
Age M = 32.61 
SD = 12.09 
 
M = 32.47 
SD = 11.00 
M = 29.01  









































Long-Term Sick Leave 
Student 
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Table 2. 
Sequence of Factor Analyses to Obtain Reduced Item Pool. 
Iteration Items Factors KMO Index Bartlett’s Test of Sphericity Items Eliminated 
1 21 6 0.737 χ2 = 858.65, df = 210, p < . 001 I notice my stomach begins to turn when exposed to vomit.a 
I become anxious when I feel nauseous.
a,b
 
It is dangerous to feel nauseous.
a
 
I worry when I feel nausea I may vomit.
a
 
I avoid eating poultry food like chicken because I may vomit.
a 
 
2 16 4 0.714 χ2 = 691.18, df = 120, p < . 001 My concern about vomiting increases when I get anxious.a,b 
I avoid places like fish markets because I may vomit.
a 
 
3 14 4 0.732 χ2 = 635.79, df = 91, p < . 001 I notice when I am anxious, my stomach gets upset.a 
 
4 13 3 0.728 χ2 = 608.93, df = 78, p < . 001  
a
Eliminated due to having no loading on any factor of > .4.   
b
Eliminated due to having communality < .3 
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Table 3. 
Factor Loadings and Communalities for the Final Three-Factor Solution. 
 Factor Loadings  
Item I II III Communality 
I avoid air travel because I may become nauseous/vomit. .79   .58 
I avoid other forms of transport because I may become nauseous/vomit. .75   .48 
I avoid sea travel (boats, etc.) because I may become nauseous/vomit. .70   .48 
I avoid places where there are no facilities to cater if I become nauseous/vomit. .59   .62 
I avoid places where there is no medical attention, because I may become nauseous/vomit. .54   .55 
I avoid fast-moving activities like rides at the theme park, because I may vomit. .51   .34 
If I see vomit, I may be sick myself.  1.00  .91 
If I smell vomit I may be sick myself.  .96  .91 
Exposure to vomit can cause sickness and/or illness.  .54  .37 
I avoid adults who may be likely to vomit.   .86 .63 
I avoid children who may be likely to vomit.   .80 .57 
I avoid places where others may vomit.   .71 .51 
I notice physical anxiety symptoms when exposed to vomit.   .52 .31 
Note. Only loadings >.4 are shown 
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Table 4. 
Correlations Between EmetQ-13 Subscales and Total Score. 
 Emetophobic Sample  Control Sample 
Subscale I II III  I II III 
II .37***    .33**   
III .21* .19   .39*** .53***  
Total .88*** .69*** .48***  .71*** .75*** .83*** 
* p < .05, ** p < .01, *** p < .001 
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Table 5. 
Correlations Between EmetQ-13 Total and Related Measures (Emetophobic Sample). 
 EmetQ-
13 
SPOVI DS-R OCI PHQ-9 GAD-7 HAI WSAS 
EmetQ-
13 
(.82)        
SPOVI .45*** (.91)       
DS-R .33** .34** (.82)      
OCI .38** .49*** .34** (.94)     
PHQ-9 .35** .47*** .24* .57*** (.92)    
GAD-7 .38*** .55*** .19 .53*** .83*** (.92)   
HAI .43*** .60*** .30** .54*** .52*** .59*** (.91)  
WSAS .50** .52*** .28* .43*** .49*** .49*** .42*** (.69) 
* p < .05, ** p < .01, *** p < .001 
 
Note. Cronbach’s α coefficients for the Emetophobia sample are displayed in 
parentheses along the diagonal.  EmetQ-13 = Emetophobia Questionnaire, SPOVI = 
Specific Phobia of Vomiting Inventory, DS-R = Disgust Sensitivity – Revised, OCI = 
Obsessive Compulsive Inventory, PHQ-9 = Personal Health Questionnaire, GAD-7 = 
Generalized Anxiety Disorder 7, HAI = Health Anxiety Inventory Short Version, 
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Table 6. 
Correlations Between EmetQ-13 Total and Related Measures (Control Sample). 
 EmetQ-
13 
SPOVI DS-R OCI PHQ-9 GAD-7 HAI 
EmetQ-
13 
(.85)       
SPOVI .25* (.81)      
DS-R .56*** .30** (.89)     
OCI .37** .19 .36** (.97)    
PHQ-9 -.24 .19 .04 .45*** (.94)   
GAD-7 .10 .27* .15 .71*** .84*** (.95)  
HAI .26* .41*** .40*** .50*** .18 .47*** (.88) 
* p < .05, ** p < .01, *** p < .001 
 
Note. Cronbach’s α coefficients for the Control sample are displayed in parentheses 
along the diagonal.  EmetQ-13 = Emetophobia Questionnaire, SPOVI = Specific 
Phobia of Vomiting Inventory, DS-R = Disgust Sensitivity – Revised, OCI = 
Obsessive Compulsive Inventory, PHQ-9 = Personal Health Questionnaire, GAD-7 = 
Generalized Anxiety Disorder 7, HAI = Health Anxiety Inventory Short Version, 
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Table 7. 
Means and Standard Deviations for Each EmetQ-13 Subscale and Total Score. 
 Emetophobic 
M ± SD 
Control 
M ± SD 
 
Comparison of Means 
Subscale I* 2.33 ± 1.04 0.39 ± 0.55 t = 15.75, df = 181, p < .001, d = 2.44 
Subscale II* 2.68 ± 1.20 1.39 ± 1.02 t = 7.79, df = 182, p < .001, d = 1.16 
Subscale III* 3.76 ± 0.52 1.01 ± 0.93 t = 24.79, df = 182, p < .001, d = 3.79 
Total
†
 37.25 ± 8.91 10.58 ± 7.63 t = 21.19, df = 173, p < .001, d = 3.23 
    
 Emetophobic 
M ± SD 
Anxious 
M ± SD 
 
Comparison of Means 
Subscale I* 2.33 ± 1.04 1.81 ± 0.72 t = 2.13, df = 111, p = .035, d = 0.59 
Subscale II* 2.68 ± 1.20 2.63 ± 0.94 t = 0.15, df = 112, p = .883, d = 0.05 
Subscale III* 3.76 ± 0.52 2.08 ± 0.96 t = 11.04, df = 112, p < .001, d = 2.27 
Total
†
 37.25 ± 8.91 27.05 ± 8.90 t = 4.64, df = 109, p < .001, d = 1.15 
Note.  Subscale scores are computed as the mean of individual item scores, to allow for 
comparison between subtests with different numbers of items.  The total score is computed as 
the total of individual item scores. 
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Table 8. 
Sensitivity and Specificity for EmetQ-13 Cutoff Scores. 
EmetQ-13 Cutoff Sensitivity Specificity 
>10 1.00 .51 
>15 1.00 .74 
>20 .97 .89 
>22 .96 .94 
>25 .90 .95 
>30 .79 .99 
>35 .55 1.00 
>40 .37 1.00 
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Figure Captions 
Figure 1.  ROC Curve for EmetQ-13 Total Score 
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